靶点针对疾病信息38(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
INDICATI
Phase 3 Female genital tract noninflammatory disorder [ICD-11: GA1Y]
INDICATI
Phase 3 Female pelvic pain [ICD-11: GA34]
INDICATI
Phase 3 Hyper-lipoproteinaemia [ICD-11: 5C80]
INDICATI
Phase 2 Breast in situ carcinoma [ICD-11: 2E65]
INDICATI
Phase 2 Diabetes mellitus [ICD-11: 5A10]
INDICATI
Phase 2 Prostate cancer [ICD-11: 2C82]
INDICATI
Phase 1 Brain cancer [ICD-11: 2A00]
INDICATI
Phase 1 Metastatic tumour [ICD-11: 2D50-2E2Z]
INDICATI
Withdrawn from market Trematode disease [ICD-11: 1F8Y]
INDICATI
Discontinued in Phase 3 Pain [ICD-11: MG30-MG3Z]
INDICATI
Discontinued in Phase 2 Eye disorder [ICD-11: 9A01-9A0Z]
INDICATI
Discontinued in Phase 1 Dissociative neurological symptom disorder [ICD-11: 6B60]
INDICATI
Discontinued in Phase 1 Thrombocytopenia [ICD-11: 3B64]
INDICATI
Preclinical Atrophy [ICD-11: 9A2Y-9C40]
INDICATI
Preclinical Joint pain [ICD-11: ME82]
INDICATI
Preclinical Sexual dysfunction [ICD-11: HA00-HA01]
INDICATI
Investigative Leukaemia [ICD-11: 2A60-2B33]